# Ouro Medicines funding rounds and investors

As of 14 Oct 2026, Ouro Medicines has raised $120M across 1 verified round on record; latest: $120 million Series A led by New Enterprise Associates, Norwest and 1 other, announced 10 Jan 2025.

Ouro Medicines develops treatments for immune-mediated diseases, targeting patients with such conditions.

Website: https://ouromedicines.com  
Headquarters: San Francisco  
Page: https://fireround.dev/companies/ouromedicines.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-01-10 | Series A | $120 million | New Enterprise Associates, Norwest, TPG Life Sciences Innovations | Boyu/Zoo Capital, GSK, LongRiver Investments, Monograph, UPMC Enterprises | [prnewswire.com](https://www.prnewswire.com/news-releases/ouro-medicines-launches-to-define-the-future-of-treatment-for-people-with-immune-mediated-diseases-302347583.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.